Acquired by Alexion
Therapies for rare diseases with high unmet medical need. Clinical stage.
Lexington, MA
NASDAQ: GEVA
Total raised: $70M
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 21.03.2011 | - | $25M | - | finsmes.co... |
| 20.10.2009 | - | $45M | - | finsmes.co... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 19.07.2011 | AIDS drug ... | Trimeris’s only product is ant... | - | - | medcitynew... |
| 13.06.2011 | AIDS drug ... | Synageva was founded in 2008. ... | - | - | medcitynew... |
| 21.03.2011 | Synageva B... | Synageva BioPharma Corp., a Le... | funding P... | - | finsmes.co... |
| 20.10.2009 | Synageva B... | Synageva BioPharma Corp., a bi... | Private Eq... | - | finsmes.co... |
| - | AIDS drug ... | AIDS drug company Trimeris‘s (... | - | - | medcitynew... |
| - | AIDS drug ... | AIDS drug company Trimeris (NA... | - | - | medcitynew... |